Lecture psychiatric disorders 9: depression Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What are diagnostic criteria for depression?

A
  • Decreased or irritable mood
  • Decreased interest in pleasurable activiteit and ability to experience pleasure
  • Significant wight gain or loss
  • Insomnia or hypersomnia
  • Psychomotor agitation or retardation
  • Fatigue or loss of energy
  • Feelings of worthlessness or excessive guilt
  • Diminished ability to think or concentrate
  • Recurrent thought of death or suicide.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is a lifestyle disease?

A

A disease that appears to increase in frequency as countries become more industrialized and people live longer.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Is depression a lifestyle disease?

A

No, it’s not a lifestyle disease. The WHO performed a study in 15 cities (including cities in Africa and China). There was a hugh variation in depression prevalence, but this was not related to sociodemographic variables.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is hard about diagnosing depression?

A
  • There’s lack of objective diagnostic tests, since depression is a compilation of symptoms.
  • Diagnosis is variable, due to the heterogeneity of the illness.
  • There’s no clear line in distinguishing people with mild clinical depression from those having a tough time in the course of their normal life.
  • Diagnostic categories are solely based on verbal information. There’s a need for biomarkers.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the monoamine hypothesis?

A

It states that the underlying pathophysiologic basis of depression is a depletion in the levels of serotonin, norepinephrine and/or dopamine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why was it thought that the monoamine hypothesis laid base to the underlying causes of depression?

A

Because drugs that act on serotonin and/or noradrenalin pathways relieve symptoms of depression within few weeks. Only, this was way to simplistic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is a new paradigm thought to be important in depression?

A

That depressive symptoms are increasingly linked to malfunctioning specific brain circuits. This could be due to genes and environmental risk factors that conspire to produce inefficient information processing in neuronal circuitry.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Study picture for an overview of all current hypothesises for the etiology of depression. Most of them will be discussed here.

A

Ok

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What would be the relationship between depression and an overactive amygdala? What other brain region is involved in this?

A

It is seen that saying positive, negative or neutral words to depressed people results in a bigger and overactive response of the amygdala and a decreased response of the prefrontal cortex compared to non-depressed people. This overactivation of the amygdala and decreased activity of the prefrontal cortex makes sense, since they’re connected in a circuit.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

So depression is characterized by an increased and sustained emotional reactivity. What does this result in (especially in response to emotional information)?

A

Involuntary elaboration on the negative topics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What’s interesting about the decreased activity of the dorsolateral prefrontal cortex (DL-PFC) in response to cognitive tasks?

A

That there are no performance deficits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What can be the interaction between the amygdala and the dorsolateral PFC?

A

That the amygdala is responsible for the inhibition of the DL-PFC and that there might be insufficient communication between the two brain regions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

It is also seen that patients with depression have an attenuated response to sad faces.

Two studies were performed that had a similar effect on depression. The first was the administration of Selective Serotonin Reuptake Inhibitors (SSRIs) to patients with depression. The other study used cognitive behavioral therapy. What were the conclusions of these studies?

A

That administration of SSRIs decreased the amygdala activity, the patients felt better and their facial sadness expression recognition normalizes.

So pharmacotherapy and behavioral therapy can normalize amygdala and PFC functioning.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Some studies found a reduction in hippocampal volume in patients with Major Depressive Disorder (MDD), others did not. What is a possible explanation of these contradictory results?

A
  • Hippocampal volume is dependent upon suptype of depression.
  • It might be that reduced hippocampal volume is a characteristic for depression, but normal hippocampal volume is restored when successfully treated. And that the hippocampal volume is also normal in healthy non-depressed people.
  • Reduced hippocampal volume might be an indicator for vulnerability for depression in healthy people.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What was found in a study where they researched healthy girls at (familial) risk for depression (due to mothers having recurrent episodes of depression)?

A

That compared with individuals at low familial risk of the development of depression, high-risk individuals have a reduced hippocampal volume.
This supports what has been discussed in the previous question, namely that reduced hippocampal volume might be an indicator for vulnerability for depression in healthy people.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Another study focused on hippocampal anatomy, where the volume of hippocampal subregions was measured (head, body and tail). What was found?

A
  • That a decreased hippocampal tail and head volume could be trait changes (i.e. vulnerability markers).
  • Hippocampal body changes may be dependent on actual mood state or in other words: dependent on if someone is depressed or treated/non-depressed.
  • Long-term antidepressant not only enhance mood, but also restore/affect hippocampal volume in depressed patients.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What could be the cause of the reduction in volume of the hippocampus and PFC?

A
  1. Loss of volume neurons → dendritic atrophy, spine loss and decreased neuronal synapses
  2. Loss of number of neurons → inhibition of neurogenesis (in hippocampus)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

The stress systems of our body are made up of two systems: the fast- and slow-acting pathway. What system is usually activated in what situation?

A

The fast-acting pathway is responsible for responding to short stress stimuli. If these stress stimuli become prolonged, the slow-acting pathway is activated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Descibe the slow-acting pathway and explain what happens when you’re depressed.

A

When stress is prolonged, the slow-acting pathway is activated. The HPA axis is activated, where the hypothalamus releases corticotropin releasing hormone (CRH) and AVP. CRH stimulates the pituitary gland to release ACTH, which stimulates adrenal gland to produce glucocorticoids like cortisol. Cortisol is able to interact with almost every bodily cell.

Normally cortisol is able to inhibit its own production, through a negative feedbackloop to the brain. Here, it binds to glucocorticoid receptors (GR) in the hypothalamus and pituitary. In depression, this negative feedbackloop fails and cortisol production is continued, which causes chronic stress.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

So what things are found in (some suptypes of) depression in regard to the HPA-axis?

A
  • A persistent finding is overactivation of the HPA-axis in some suptypes of depression.
  • Increased peripheral plasma cortisol concentrations
  • Elevated levels of CRH in the brain
  • Reduced glucocorticoid receptors (GR) in hippocampus and hypothalamus
  • Negative feedback loop unable to shut down stress system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Fill in:

A healthy stress system is a stress system with plenty of … (1)

A

A healthy stress system is a stress system with plenty of glucocorticoid receptors (in the brain).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are symptoms of chronic stress via cortisol and CRH?

A

Decreased appetite, weight loss and loss of libido.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

How can these symptoms of chronic stress be explained?

A

Since the negative feedbackloop of cortisol isn’t working, also the concentrations of CRH (also known as CRF) are increased in the brain. And also CRH can interact with receptors in certain brain areas. There are two variants of CRF which stimulate pathways in the brain that are responsible for these symptoms. See picture.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

So it’s clear that normalization of the HPA-axis is a necessity for stable remission of symptoms. How can this be done?

A

Already is stated that a healthy stress system, a stress system is with plenty of cortisol receptors in the brain. Antidepressants and psychotherapy can be used to restore efficient negative feedback by increasing gene/protein expression of the cortisol receptor in the brain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What is the role of BDNF in healthy people and in depressed people?

A

BDNF → Brain Derived Neurotrophic Factor

  • BDNF is required for neuronal development early in life. In the adult brain it’s important for neuronal survival, synaptic plasticity, synaptogenesis, dendrites and neurogenesis.
  • In depressed patients, BDNF levels are severly decreased in PFC, hippocampus and blood.
26
Q

Does chronic administration of antidepressants and other treatments increase BDNF expression (based on meta-analyses)?

A

Yes, there’s strong evidence for this.

27
Q

How can the HPA-axis, hippocampal volume and BDNF be linked together?

A

We’ve already stated that a reduced hippocampal volume can be the result of two things: loss of volume neurons (dendritic atrophy, spine loss and decreased neuronal synapses) and loss of number of neurons (inhibition neurogenesis). High sustained levels of cortisol causes both loss of neuronal volume as loss of neuronal numbers, by inhibiting BDNF.

28
Q

How does cortisol cause a loss of number and volume of neurons via i.a. BDNF?

A
  • Loss of volume → high cortisol levels are toxic for hippocampal neurons (→ dendritic atrophy, spine loss and decreased neuronal synapses).
  • Loss of numbers → inhibition birth of new granule cells in hippocampal dentate gyrus (→ decreased neurogenesis)
29
Q

The reason behind an overactive HPA-axis could be a combination of genetic, epigenetic and environmental factors that could affect regulation of HPA axis. Name examples of these different factors that could contribute to HPA-axis overactivation.

A
  • Genetic → variations in gene-variants for protein important in HPA-axis
  • Epigenetic & environmental → early experiences, stress during pregnancy, stress during post-natal life, poor parental care, childhood abuse, etc.
30
Q

Explain the brain-gut axis hypothesis.

A

The gut also contains neurons and neurotransmitters, referred to as the ‘gut brain’. The gut brain is connected to the brain bidirectionally. Furthermore, the gut contains millions of microbes (gut microbiome) that release metabolites and other molecules. The molecules that are released by the microbiome, in combination with the brain-gut connections, is thought to influence the probability of brain disorders or in general our health in our body.

31
Q

So there’s increasing evidence of the role of the gut microbiome in health and disease. What is current research focused on?

A

Research into the effects of food, antibiotics, probiotics (psychobiotics) on mood.

32
Q

What is seen in patients with inflammation or an inflammatory disease?

A

Inflammation causes innate immune cells to produce pro-inflammatory cytokines that act on the brain to cause sickness behaviour. If inflammation is persistent (e.g. systemic infections, cancer or autoimmunr diseases), the continued immune signaling can lead to excerbation of sickness symptoms and the development of symptoms of depression.

It then also makes sense that there’s similarity between sickness behaviour and depression (withdrawal from physical and social environment that is accompanied by pain, malaise and decreased reactivity to reward (anhedonia))

33
Q

What cytokines were found to be increased in a meta-analysis of cytokines in major depression disorder (MDD)?

A

TNF-α and IL-6.

34
Q

What is sickness behaviour?

A

Social withdrawal, decreased exploratory and sexual behaviour.

35
Q

What happens when patients get treated with recombinant cytokines IL-2 and IFN-α, such as in treatment of Hepatitis C?

A

⅓ develops depression

36
Q

What disease has co-morbidity with depression?

A

Coronary heart disease (inflammation is a major factor here). The prevalence of co-morbitidy between coronary heart disease and depression is three times higher than in the general population.

37
Q

So what drugs could accelerate the response to SSRIs?

A

Anti-inflammatory drugs, such as NSAIDs or other anti-inflammatory agents such as mega-3-polyunsaturated fatty acids (PUFA) in fat fish or supplements

38
Q

What is the circadian rhythm?

A

It’s the natural process that regulates the sleep-wake cycle and repeats roughly every 24 hours. It’s a central clock in the suprachiasmatic nucleus (SCN) in the hypothalamus that consists of 50.000 pacemaker neurons.

39
Q

How is the circadian rhythm generated?

A

It’s thought to depend on the activity of a key group of clock genes generating an automatic independent 24-hour periodicity. Here, the suprachiasmatic nucleus (SCN) receives light and dark information directly from the retina via the retinohypothalamic tract (RHT). The SCN then synchronizes peripheral clocks that are present in most cells of the body.

Summarized:

Light and dark information is caught by the retina of the eye → signal passed on to the retinohypothalamic tract (RHT) → signal passed on to the suprachiasmatic nucleus (SCN) → regulation of clock genes.

40
Q

How can disruption in the circadian rhythm cause depression (and also the other way around: how can depression cause disruption of the circadian rhythm)?

A

A depressed person can have early morning awakenings, which causes a phase shift in the biological clock (disruption of this clock can then enhance depression further).

41
Q

What can be used as a treatment for a disturbed circadian rhythm in depressed patients?

A

Sleep deprivation or exposure to light (light-therapy), which results in another (correct) phase shift, thereby ameliorating depressive symptoms.

42
Q

What is a drug treatment that acts on the circadian rhythm in order to treat depressed patients?

A

The antidepressant agomelatine, a synthetic melatonin receptor agonist in combination with a serotonin 2C receptor antagonist.

43
Q

Animal research has linked circadian rhythm disruption during depression with two other hypothesises. What two?

A

Cytokine and neurogenic hypothesis.

44
Q

In animal research (mouse model) they induced depression by long-term light deprivation in constant darkness. Through this study chronobiological, cytokine and neurogenic models could be linked together. Expain what results were found in this study that linked these models together.

A

After 4 weeks of light deprivation they measured the following:

  • Cytokine hypothesis → elevated levels of IL-6.
  • Chronobiological / Disrupted circadian rhythm hypothesis → altered hippocampal gene expression of clock genes per2 and npas2.
  • Neurogenic hypothesis → reduced neurogenesis in hippocampus.
45
Q

What is ketamine and how can ketamine be used in the treatment against depression?

A

Kertamine is an NMDA-antagonist that is able to produce rapid antidepressant responses in treatment resistant patients, these effects lasts 1-2 weeks.

Ketamine induces synaptogenesis, neurogenesis and reversal of atrophy caused by chronic stress.

46
Q

Why does ketamine work so fast?

A

Because ketamine can induce synaptogenesis and neurogenesis via a complex pathway (mTOR). This targets the core problems of depression (i.a. reduced neurogenesis in hippocampus).

47
Q

Several (clinical) studies have been developed to find a ketamine drug that works for depression. Name these (I really don’t know if this is important)

A
  • 2010 - present: several clinical trials
  • 2019: Nasal Spray containing esketamine for adults with treatment-resistant depression, developed by Janssen
  • UMC Groningen, pilot study ketamine antidepressant
  • UMC Groningen + AMC Amsterdam, clinical trial for oral ketamine in depression (oral administration has less disadvantages)
48
Q

What’s another treatment that can be used in patients with treatment resistant depression?

A

Psilocybin-assisted psychotherapy. Psilocybin is an active substance from psychodelic mushrooms. The substance causes an hallucinogenic experience. In treatment, this hallucinogenic experience is combined with therapy. (This is an ongoing trial).

49
Q

What does psilocybin cause that relieves depressive symptoms?

(Not completely clear if we need to learn this)

A

It reduces amygdala activity and affects the default mode network.

50
Q

What were the conclusions of a systemic review and meta-analysis about meditation programs for psychological stress and well-being?

A

That mindfullness meditation programs had a moderate improvement in anxiety within 8 weeks. There was also small (postive) effects for depression and pain measured within half a year. The study concludes that doctors should take these results into account when starting a treatment for a depressed patient.

51
Q

Give an estimation of heritability of major depressive disorder (MDD), severe depression, less severe depression and bipolar depression.

A
  • MDD → relatively low heritability
  • Severe → 50%
  • Less severe → 25%
  • Bipolar → 80%
52
Q

Name 3 genes for which there is strong evidence of a link to depression.

A

FKBP5, HTR2A, GRIK4

53
Q

What is one of the reason why we still understand so little about these risk genes?

A

Because there are complex interactions between genes and the environment.

54
Q

An influential prospective study by Caspi et al. looked for the influence of life stress on depression. What was measured in this study?

A
  • The number of stressful life events was measured of people between age 21-26.
  • The presence of (a type of) depression at age 26
  • There’s polymorphism for the serotonin transporter gene (5-HTT). The polymorphism exists of a short allele (S) or a long allele (L). So three genotypes exist: SS, SL or LL. In this study, the 5HTT genotype was measured.
55
Q

What was the outcome of this influential prospective study by Caspi et al. that looked for the influence of life stress on depression?

A

Of the three genotypes/variants of the 5-HTT, the homozygous variant for allele S (S/S) was associated with an increased chance of depression when the amount of stressful life events increased. The homozygous variant for allele L (L/L) showed the lowest chances of developing depression when the amount of stressful life events was high. So you could state that genotype L/L is resilient to life stress.

56
Q

Does a specific genotype (so L/L, S/S or S/L) cause depression?

A

No, the genotypes on their own do not cause depression. When there are no stressful live events, the genotype doesn’t influence the chance of depression. This is only the case, when the number of stressful life events increase. Only then, the genotype (L/L, S/S or S/L) determines the chance of developing depression.

In this way only, the chances are highest to develop depression if you carry the S/S genotype and when the number of stressful life events have increased.

57
Q

So the previous study, looked into one genetic-environmental interaction. Another study looked for a broader correlation, between the 5-HTT and BDNF genotype and whether the genotype in combination with the degree of life adversity (here; maltreatment of children) would indicate higher chances of the development of depression.

What variants are there for BDNF?

A

BDNF - val/met

BDNF - val/val

58
Q

So the previous study, looked into one genetic-environmental interaction. Another study looked for a broader correlation, between the 5-HTT and BDNF genotype and whether the genotype in combination with the degree of life adversity (here; maltreatment of children) would indicate higher chances of the development of depression.

What was the outcome of this study in regard to the control and maltreated group of people?

A

That there was a significant three-way interaction between the BDNF genotype, 5-HTTL genotype and maltreatment history.

  • Children with the BDNF gene val66met polymorphism and the S/S 5-HTT genotype had the highest depression scores.
  • Vulnerability associated with these genotypes was only elevated in maltreated children.
59
Q

So the previous study, looked into one genetic-environmental interaction. Another study looked for a broader correlation, between the 5-HTT and BDNF genotype and whether the genotype in combination with the degree of life adversity (here; maltreatment of children) would indicate higher chances of the development of depression.

Now they also looked at the degree of social support in combination with the degree of maltreatment. What was the outcome of this study in regard to the maltreated group (high social support vs low social support)?

A

Here, a significant four-way interaction emerges.

  • The depression scores of the maltreated children with high social support were close to the mean depression score of the control subjects, regardless of genotype.
  • The S/S genotype was associated with an increase in maltreated children’s depression scores, which was greatest for the children without social support. If this was in combination with the Val66Met genotype, the depression score would be even higher.
60
Q

What are other treatments or therapies that seem to work for depression?

A
  • Regular aerobic exercise → induces neurogenesis and normalization of the HPA-axis
  • Deep Brain Stimulation
  • Transcranial Magnetic Stimulation (TMS)
  • Electro-Convulsive Therapy